-
Xenobiotic Transporter Response to Olsalazine in Aedes aegyp
2026-08-03
Kennel and Rouhier (2025) investigated how Aedes aegypti mosquitoes manage xenobiotic clearance and transporter gene expression in response to synthetic dyes, including Olsalazine Sodium. Their study identifies novel organic cation transporter candidates and reveals that the chemical structure of xenobiotics, rather than transporter mRNA modulation, drives differences in excretion and physiological outcomes—providing new insight for vector control strategies.
-
Partial BACE1 Inhibition Preserves Synaptic Function in AD M
2026-08-03
Satir et al. (2020) demonstrate that partial inhibition of BACE1—resulting in up to a 50% reduction of amyloid-beta production—does not impair synaptic transmission in cultured neurons. This finding refines the therapeutic window for BACE1 inhibitors such as Lanabecestat and informs strategy in Alzheimer’s disease research.
-
nor-NOHA Acetate: Optimizing Arginase Inhibition in Cancer M
2026-08-02
nor-NOHA (acetate) unlocks precise control of arginine metabolism, offering translational researchers a potent, reversible arginase inhibitor to dissect immune escape, apoptosis, and migration in cancer systems. Advanced workflows and troubleshooting insights empower reproducible, high-impact studies using APExBIO’s high-purity nor-NOHA (acetate) reagent.
-
Etomoxir: Transforming Immunometabolic Research in Translati
2026-08-01
Unravel how Etomoxir (R-(+)-Etomoxir) redefines immunometabolic assays by enabling precision modulation of the fatty acid oxidation pathway. This thought-leadership article provides mechanistic context, protocol recommendations, and strategic guidance for translational researchers, referencing recent standardized whole-blood stimulation protocols and highlighting APExBIO’s Etomoxir as a research-critical tool.
-
Dasatinib Monohydrate in Patient-Derived Assembloid Research
2026-07-31
Dasatinib Monohydrate (BMS-354825) is transforming kinase inhibition studies by enabling high-fidelity drug response profiling in patient-derived assembloid models. This article unpacks the practical workflow enhancements, troubleshooting advice, and translational advantages of using Dasatinib in complex tumor microenvironments—supported by the latest assembloid research breakthroughs.
-
TAK-242 (Resatorvid): Translating TLR4 Inhibition into Postt
2026-07-31
Explore how TAK-242 (Resatorvid), a selective TLR4 inhibitor, is reshaping neuroinflammation and posttraumatic epilepsy research. This article provides advanced scientific insights on mechanism, protocol design, and practical implications, going beyond general inflammation models.
-
SCP4 Phosphatase Regulates H3T3 Dephosphorylation in Mitosis
2026-07-30
This study identifies SCP4 as the nuclear phosphatase responsible for dephosphorylating histone H3 at threonine 3 (H3T3) during mitosis, a crucial step for accurate chromosome segregation. These findings clarify a key regulatory mechanism ensuring chromosome stability and offer new directions for research into genomic maintenance.
-
DMH1 as a Selective ALK2 Inhibitor: Optimizing Organoid and
2026-07-30
Harness the precision of DMH-1 for targeted BMP pathway inhibition in organoid and non-small cell lung cancer (NSCLC) models. Discover actionable workflows, troubleshooting insights, and protocol enhancements that distinguish DMH-1 as a gold-standard ALK2 inhibitor for high-fidelity cell signaling studies.
-
Imatinib (STI571) in Cell Assays: Protocols, Data, and Relia
2026-07-29
This article addresses common laboratory challenges in cell viability and kinase pathway assays, demonstrating how Imatinib (STI571) (SKU B2171) delivers reproducible, high-sensitivity results. Drawing on published evidence and direct product specifications, we explore optimal workflow design and practical troubleshooting for researchers using this selective kinase inhibitor.
-
Plant Cell Lysis Buffer for WB and IP: High-Fidelity Protein
2026-07-29
Plant Cell Lysis Buffer for WB and IP enables efficient, non-denaturing protein extraction from plant tissues for Western blotting and immunoprecipitation applications. Its proprietary blend of detergent and inhibitors preserves native protein interactions, supporting high downstream assay fidelity. The K1126 kit from APExBIO is benchmarked for stability and compatibility across multiple species.
-
Cyanine 3 Tyramide: Fluorescent Dye for Biomedical Research
2026-07-28
Cyanine 3 Tyramide empowers scientists with high-sensitivity fluorescence labeling, enabling robust signal amplification in immunohistochemistry, in situ hybridization, and flow cytometry. Applied in cutting-edge neuroscience, this dye streamlines workflows and enhances reproducibility, even when detecting low-abundance targets.
-
Poly(I:C): Synthetic Double-Stranded RNA Analog in Immune Ac
2026-07-28
Poly(I:C) stands out as the gold-standard synthetic double-stranded RNA analog for modeling interferon-driven innate immunity and dendritic cell maturation. This guide delivers actionable protocols, troubleshooting strategies, and insights from translational research, empowering scientists to harness Poly(I:C) for cutting-edge immunology and regenerative medicine workflows.
-
Stattic: Selective STAT3 Inhibitor for Cancer Biology Resear
2026-07-27
Stattic is a potent, selective STAT3 inhibitor with demonstrated efficacy in head and neck squamous cell carcinoma models. It blocks STAT3 dimerization and nuclear translocation, leading to reduced cancer cell survival and enhanced radiosensitivity. Stattic's properties enable reproducible interrogation of STAT3 signaling in cancer biology.
-
Porcupine Inhibition for Sclerosteosis: Mechanistic Insights
2026-07-27
This article examines a recent study that demonstrates the therapeutic potential of PORCN inhibition using LGK974 in sclerosteosis, a rare high bone mass disorder caused by SOST mutations. The research leverages in vitro and in vivo models to elucidate how targeted Wnt pathway suppression can mitigate excessive bone formation, offering a possible alternative to high-risk surgical interventions.
-
Indole-3-pyruvic Acid: Translating Mechanistic Insight to Im
2026-07-26
This thought-leadership article unpacks the emerging significance of Indole-3-pyruvic acid (IPA) as a molecular nexus connecting plant hormone biosynthesis and mammalian immune modulation. By blending mechanistic insight, recent translational breakthroughs, and strategic guidance, it guides researchers in deploying IPA (available from APExBIO) for next-generation studies in both plant and biomedical domains. The discussion is grounded in recent evidence, including landmark rheumatoid arthritis research, and highlights how IPA's unique duality offers new opportunities for translational discovery.
449 records 9/30 page Previous Next First page 上5页 678910 下5页 Last page